Gelteq Limited (GELS)

Gelteq will go public soon, but the exact IPO date is still unknown.
IPO Price
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 47.19M
Revenue (ttm) 353
Net Income (ttm) -1.68M
Shares Out 9.44M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About GELS

Gelteq is a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. A “white label” gel-based delivery solution is where we produce a product that other companies rebrand as their own product. Our principal products are edible gels and their application in gel-based dosage forms. Our current product suite consists of multiple products that sit within five core verticals — for pets, sports, pharmaceutical (ph... [Read more]

Industry Health Care
Sector Pharmaceuticals
Founded 2018
Employees 5
Stock Exchange NASDAQ
Ticker Symbol GELS
Full Company Profile

Financial Performance

Financial numbers in AUD Financial Statements


Gelteq IPO Registration Document (F-1)

Gelteq has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC